Exclusion of Ranitidine From Premedication Regimens During Paclitaxel Treatment.

Huntjens, Daan W; Vanhommerig, Joost W; van de Veen, Willem; Crul, Mirjam

Huntjens, Daan W; Vanhommerig, Joost W; van de Veen, Willem; Crul, Mirjam.

Afiliação

Huntjens DW; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Vanhommerig JW; Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, the Netherlands.
van de Veen W; Department of Research and Epidemiology, OLVG Hospital, Amsterdam, the Netherlands.
Crul M; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

JAMA Oncol ; 10(1): 131-132, 2024 Jan 01.

Article em En | MEDLINE | ID: mdl-37917074

This cohort study conducted in the Netherlands uses electronic medical records to assess incidence of hypersensitivity reactions with and without H2-receptor antagonist premedication before paclitaxel administration.

Assuntos

Paclitaxel; Ranitidina; Humanos; Paclitaxel/efeitos adversos; Ranitidina/efeitos adversos; Dexametasona/uso terapêutico; Infusões Intravenosas; Pré-Medicação

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ranitidina / Paclitaxel Limite: Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google